September 9, 2013

High ‘Cholera Sell’? Vouching for Paxvax’s Phase III Strategy

Source: BioWorld Today
Publication Date: September 9, 2013
Visit Source

As PaxVax enters Phase III trials for the once-daily, oral cholera vaccine, BioWorld Today discusses the company’s priority review voucher and potential to be the first cholera vaccine approved for marketing in the U.S.